Search research articles
Contact Us
Filters
Showing results (21-30 of 127) with videos related to
Page
of 13
Sort By:
Translational Stroke Research
|
July 17, 2019
Adult Neurogenesis in the Subventricular Zone and Its Regulation After Ischemic Stroke: Implications for Therapeutic Approaches
Yörg Dillen, Hannelore Kemps, Pascal Gervois, et al.
European Journal of Immunology
|
January 1, 1991
A single amino acid substitution in the Ak molecule fortuitously provokes an alloresponse
P Dellabona, B Y Wei, N Gervois, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 21, 2006
Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence
Alberto Zambon, Philippe Gervois, Paolo Pauletto, et al.
Nutrients
|
December 9, 2023
Gut-Joint Axis: Impact of Bifidobacterial Cell Wall Lipoproteins on Arthritis Development
Frank Piva, Philippe Gervois, Youness Karrout, et al.
Bulletin Du Cancer
|
September 6, 2003
[Passive immunotherapy of melanoma]
Francine Jotereau, Nathalie Labarriere, Nadine Gervois, et al.
Stem Cells International
|
October 12, 2017
The Angiogenic Potential of DPSCs and SCAPs in an <i>In Vivo</i> Model of Dental Pulp Regeneration
Petra Hilkens, Annelies Bronckaers, Jessica Ratajczak, et al.
Cancer Immunology, Immunotherapy : CII
|
July 25, 2007
PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting
Nathalie Labarrière, Nadine Gervois, Annabelle Bonnin, et al.
Bulletin Du Cancer
|
September 25, 2018
[Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment]
Tilda Passat, Yann Touchefeu, Nadine Gervois, et al.
European Journal of Immunology
|
October 1, 1995
HLA class II-restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma-infiltrating lymphocytes
E Le Dréan, N Gervois, E Diez, et al.
International Immunology
|
October 1, 1995
T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro
C Viret, N Gervois, Y Guilloux, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 127) with videos related to
Sort By:
Page
of 13
Translational Stroke Research
|
July 17, 2019
Adult Neurogenesis in the Subventricular Zone and Its Regulation After Ischemic Stroke: Implications for Therapeutic Approaches
Yörg Dillen, Hannelore Kemps, Pascal Gervois, et al.
European Journal of Immunology
|
January 1, 1991
A single amino acid substitution in the Ak molecule fortuitously provokes an alloresponse
P Dellabona, B Y Wei, N Gervois, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 21, 2006
Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence
Alberto Zambon, Philippe Gervois, Paolo Pauletto, et al.
Nutrients
|
December 9, 2023
Gut-Joint Axis: Impact of Bifidobacterial Cell Wall Lipoproteins on Arthritis Development
Frank Piva, Philippe Gervois, Youness Karrout, et al.
Bulletin Du Cancer
|
September 6, 2003
[Passive immunotherapy of melanoma]
Francine Jotereau, Nathalie Labarriere, Nadine Gervois, et al.
Stem Cells International
|
October 12, 2017
The Angiogenic Potential of DPSCs and SCAPs in an <i>In Vivo</i> Model of Dental Pulp Regeneration
Petra Hilkens, Annelies Bronckaers, Jessica Ratajczak, et al.
Cancer Immunology, Immunotherapy : CII
|
July 25, 2007
PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting
Nathalie Labarrière, Nadine Gervois, Annabelle Bonnin, et al.
Bulletin Du Cancer
|
September 25, 2018
[Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment]
Tilda Passat, Yann Touchefeu, Nadine Gervois, et al.
European Journal of Immunology
|
October 1, 1995
HLA class II-restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma-infiltrating lymphocytes
E Le Dréan, N Gervois, E Diez, et al.
International Immunology
|
October 1, 1995
T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro
C Viret, N Gervois, Y Guilloux, et al.
Page
of 13